STKH Overview

Merus Acquisition: Merus NV shares surged 38.2% to $95.21 following Genmab's announcement of an $8 billion all-cash acquisition, which includes the breakthrough therapy Petosemtamab.

Pre-Market Gainers: Notable pre-market gainers included Steakholder Foods (up 92%), JFB Construction Holdings (up 77.4%), and Plus Therapeutics (up 24.3%), among others.

Pre-Market Losers: MoonLake Immunotherapeutics saw a significant drop of 86.3% after disappointing trial results, while Maris Tech and Sunrise New Energy also experienced substantial declines.

Market Overview: The article provides a snapshot of various stocks' performances in pre-market trading, highlighting both significant gainers and losers.

Acquisition Announcement: Steakholder Foods Ltd. has signed an agreement to acquire Twine Solutions Ltd., allowing Twine's shareholders to retain a minority stake in Steakholder, potentially increasing to 35% based on performance milestones.

Technological Synergy: The merger aims to combine Steakholder's 3D food printing technology with Twine's innovative digital dyeing systems, positioning the new entity to revolutionize industries such as food and textiles through enhanced manufacturing and supply chain solutions.

Acquisition Announcement: Steakholder Foods (STKH) has agreed to acquire Twine Solutions, with Twine's shareholders receiving a minority stake in Steakholder Foods in exchange for their shares.

Strategic Growth: CEO Arik Kaufman highlighted that the acquisition will diversify Steakholder Foods' income streams and enhance its commercial potential by integrating 3D food printing with Twine's dyeing technology.